The exact dosage and schedule should be determined by a healthcare provider, based on individual health needs and treatment goals
Additionally, people who have experienced pancreatitis (inflammation of the pancreas) or have severe gastrointestinal issues like gastroparesis may be at higher risk for complications when taking this medication
Patients should be informed that whilst the mechanism suggests potential cardiovascular benefits, definitive outcome data are awaited
Our mobile service brings this powerful therapy directly to you throughout Pennsylvania, making it easier than ever to prioritize your health without disrupting your busy life
The first study to demonstrate the effect of GLP-1RAs in reducing cardiovascular events was LEADER, in which 9340 patients with type 2 diabetes at high cardiovascular risk were randomized to liraglutide 1.8 mg per day or placebo [16]
Or aware of the bacterium in the gut microbiota that induces natural production of GLP-1